查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1654334

全球局部止血劑市場：市場規模、佔有率、趨勢分析（按類型、應用、最終用途和地區）、細分市場預測（2025-2030 年）

Topical Hemostat Market Size, Share & Trends Analysis Report By Type (Thrombin, Collagen, Gelatin), By Application (General Surgery, Cardiovascular Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

局部止血劑市場規模及趨勢：

全球局部止血劑市場預計將在 2024 年達到 59 億美元，2025 年至 2030 年的複合年成長率為 9.4%。

由於外科手術的增加、創傷病例的增加以及止血技術的進步，該行業正在不斷發展。這些產品廣泛用於控制心血管、整形外科和神經外科手術中的出血。需求的促進因素是更快的創傷治療、減少手術併發症和改善患者預後。醫療保健基礎設施的成長（尤其是新興市場）以及微創手術的興起將進一步推動市場成長。

最近的一個案例凸顯了紗布等傳統止血材料的限制。手術後，止血材料意外地存在於患者體內，引起疼痛、發炎和感染。紗布和醫用繃帶等傳統材料主要用於控制表皮出血，但對出血部位的黏性不足，且容易受到污染。纖維蛋白膠和膠原蛋白海綿等替代材料生物分解性，但由於依賴人類或動物來源的蛋白質，因此價格昂貴。

研究人員解決了這些限制，並利用來自貽貝和蠶繭的天然蛋白質開發了一種創新的雙層奈米纖維膜止血劑。這種新型止血材料具有強大的組織黏附性、有效的止血和感染防護功能。由浦項科技大學、梨花女子大學和首爾聖母醫院的車賢俊教授領導的聯合研究小組於 2024 年 2 月在學術期刊《Small》上發表了這項研究。此止血劑整合了能活化血小板、快速止血的貽貝黏附蛋白和用甲醇蒸氣改質的疏水性奈米纖維外層的貽貝素蛋白。這種雙層層級構造確保了生物相容性、生物分解性和強大的感染防護能力。

動物研究已證明該藥物具有促進組織黏合和出血傷口止血的能力。內層促進黏附，外層防止水傳播的污染物和細菌。這些進步解決了現有止血材料的重大缺陷，並為外科手術應用提供了更安全、更通用的解決方案。研究團隊強調，這種止血材料有可能應用於現實生活中的外科手術，對患者照護有重大影響。

業界因這些創新的認知不斷提高以及資金和研究支持而受益。該研究由韓國海洋生物材料研究中心計畫和國家研究基金會支持，強調了政府舉措在推動市場成長方面的重要性。隨著對先進、經濟高效且生物相容性的止血劑的需求不斷增加，在技術突破和對更安全手術結果的持續追求的推動下，市場預計將大幅擴張。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章局部止血劑市場：因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 局部止血劑市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析

第4章局部止血劑市場：按類型進行估計和趨勢分析

  • 細分儀表板
  • 局部止血劑市場：按類型趨勢分析
  • 局部止血劑市場前景（按類型）
  • 市場規模預測及趨勢分析（2018-2030年）
  • 纖維蛋白
  • 凝血酶
  • 纖維素
  • 膠原蛋白
  • 明膠
  • 膠水
  • 其他

第 5 章局部止血劑市場：按應用的估計和趨勢分析

  • 細分儀表板
  • 局部止血劑市場：依應用進行差異分析
  • 局部止血劑市場前景（按應用）
  • 市場規模預測及趨勢分析（2018-2030年）
  • 一般外科
  • 神經外科
  • 血管外科
  • 心血管外科
  • 其他

第6章局部止血劑市場：依最終用途的估計與趨勢分析

  • 細分儀表板
  • 局部止血劑市場：依最終用途進行差異分析
  • 局部止血劑市場前景（依最終用途）
  • 市場規模預測及趨勢分析（2018-2030年）
  • 醫院
  • 門診手術中心
  • 其他

第7章局部止血劑市場：按地區分類的估計和趨勢分析

  • 區域控制面板
  • 局部止血劑市場：依技術進行差異分析
  • 局部止血劑市場技術展望
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • BD
    • Medicom
    • Baxter
    • HemoSonics
    • Hemostasis, LLC
    • Medline Industries
    • Pfizer Inc.
    • Johnson &Johnson
    • HemCon Medical Technologies Inc.
    • Integra LifeSciences
    • Teleflex Incorporated
Product Code: GVR-4-68040-501-0

Topical Hemostat Market Size & Trends:

The global topical hemostat market size was valued at USD 5.9 billion in 2024 and is projected to grow at a CAGR of 9.4% from 2025 to 2030. The industry is growing due to rising surgical procedures, increasing trauma cases, and advancements in hemostatic technologies. These products are widely used to control bleeding in surgeries, including cardiovascular, orthopedic, and neurosurgical procedures. The demand is fueled by the need for faster wound healing, reduced surgical complications, and improved patient outcomes. Growing healthcare infrastructure, particularly in emerging markets, and the rise in minimally invasive procedures further drive market growth.

A recent case underscored the limitations of conventional hemostatic materials like gauze, where its unintended presence in a patient post-surgery caused pain, inflammation, and infection. Traditional materials such as gauze and medical bands primarily control surface bleeding but lack adherence to bleeding sites and are prone to contamination. Alternatives like fibrin glue and collagen sponges, though biodegradable, are expensive due to reliance on human or animal-derived proteins.

Researchers have addressed these limitations and developed an innovative bilayer nanofiber membrane hemostat using natural proteins from mussels and silkworm cocoons. This novel hemostat offers strong tissue adhesion, effective bleeding control, and protection against infection. Led by Professor Hyung Joon Cha and a collaborative team from POSTECH, Ewha Womans University, and Seoul St. Mary's Hospital, the research was published in the journal Small in February 2024. The hemostatic agent integrates mussel adhesive proteins, which activate platelets for rapid hemostasis, and silk fibroin from silkworms, modified with methanol vapor to create a hydrophobic nanofiber outer layer. This dual-layer design ensures biocompatibility, biodegradability, and robust infection prevention.

Animal experiments demonstrated the agent's ability to accelerate tissue adhesion and hemostasis in bleeding wounds. Its inner layer enhances adhesion while the outer layer protects against waterborne contaminants and bacteria. These advancements address critical shortcomings in existing hemostatic materials, offering a safer, multifunctional solution for surgical applications. The research team emphasized the agent's potential for real-world surgical settings and its transformative impact on patient care.

The industry benefits from growing awareness of such innovations, as well as funding and research support. This study, supported by Korea's Marine Bio Materials Research Center Program and the National Research Foundation, highlights the importance of government initiatives in driving market growth. As demand for advanced, cost-effective, and biocompatible hemostatic agents rises, the market is poised for substantial expansion, propelled by technological breakthroughs and the continuous pursuit of safer surgical outcomes.

Global Topical Hemostat Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global topical hemostat market report on the basis of type, application, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Fibrin
  • Thrombin
  • Cellulose
  • Collagen
  • Gelatin
  • Adhesives
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • General Surgery
  • Neurosurgery
  • Vascular Surgery
  • Cardiovascular Surgery
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Region Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Topical Hemostat Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Topical Hemostat Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Topical Hemostat Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Topical Hemostat Market: Type Movement Analysis
  • 4.3. Topical Hemostat Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Fibrin
    • 4.5.1. Fibrin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Thrombin
    • 4.6.1. Thrombin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Cellulose
    • 4.7.1. Cellulose Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Collagen
    • 4.8.1. Collagen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Gelatin
    • 4.9.1. Gelatin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Adhesives
    • 4.10.1. Adhesives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Topical Hemostat Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Topical Hemostat Market: Application Movement Analysis
  • 5.3. Topical Hemostat Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. General Surgery
    • 5.5.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Neurosurgery
    • 5.6.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Vascular Surgery
    • 5.7.1. Vascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Cardiovascular Surgery
    • 5.8.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Topical Hemostat Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Topical Hemostat Market: End-use Movement Analysis
  • 6.3. Topical Hemostat Market by Ens-use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Ambulatory Surgical Centers
    • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Topical Hemostat Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Topical Hemostat Market movement analysis
  • 7.3. Topical Hemostat Market: Regional Estimates & Trend Analysis by Technology & Usability
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. UK Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Germany Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. France Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Italy Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Spain Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Denmark
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Denmark Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Competitive Scenario
      • 7.6.8.3. Regulatory Framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Sweden Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.9. Norway
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Competitive Scenario
      • 7.6.9.3. Regulatory Framework
      • 7.6.9.4. Reimbursement scenario
      • 7.6.9.5. Norway Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Japan Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. China Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. India Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.6. Australia
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Australia Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Thailand Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Brazil Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Middle East & Africa
    • 7.9.1. Middle East & Africa Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. South Africa Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Saudi Arabia Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Competitive Scenario
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. UAE Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Competitive Scenario
      • 7.9.5.3. Regulatory Framework
      • 7.9.5.4. Reimbursement scenario
      • 7.9.5.5. Kuwait Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. BD
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Type benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Medicom
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Type benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Baxter
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Type benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. HemoSonics
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Type benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Hemostasis, LLC
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Type benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medline Industries
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Type benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Pfizer Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Type benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Johnson & Johnson
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Type benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. HemCon Medical Technologies Inc.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Type benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Integra LifeSciences
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Type benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Teleflex Incorporated
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Type benchmarking
      • 8.2.11.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 4. Global topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 5. Global topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 6. North America topical hemostat market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 8. North America topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 9. North America topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 10. U.S. topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 11. U.S. topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 12. U.S. topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 13. Canada topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 14. Canada topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 15. Canada topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 16. Mexico topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 17. Mexico topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 18. Mexico topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 19. Europe topical hemostat market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 21. Europe topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 22. Europe topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 23. UK topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 24. UK topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 25. UK topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 26. Germany topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 27. Germany topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 28. Germany topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 29. France topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 30. France topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 31. France topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 32. Italy topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 33. Italy topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 34. Italy topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 35. Spain topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 36. Spain topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 37. Spain topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 38. Norway topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 39. Norway topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 40. Norway topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 41. Sweden topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 42. Sweden topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 43. Sweden topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 44. Denmark topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 45. Denmark topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 46. Denmark topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific topical hemostat market, by country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 51. Japan topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 52. Japan topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 53. Japan topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 54. China topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 55. China topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 56. China topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 57. India topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 58. India topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 59. India topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 60. Australia topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 61. Australia topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 62. Australia topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 63. South Korea topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 64. South Korea topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 65. South Korea topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 66. Thailand topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 67. Thailand topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 68. Thailand topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 69. Latin America topical hemostat market, by country, 2018 - 2030 (USD Million)
  • Table 70. Latin America topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 71. Latin America topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 72. Latin America topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 73. Brazil topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 74. Brazil topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 75. Brazil topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 76. Argentina topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 77. Argentina topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 78. Argentina topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 79. Middle East & Africa topical hemostat market, by country, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 83. South Africa topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 84. South Africa topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 85. South Africa topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 89. UAE topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 90. UAE topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 91. UAE topical hemostat market, by end-use, 2018 - 2030 (USD Million)
  • Table 92. Kuwait topical hemostat market, by type, 2018 - 2030 (USD Million)
  • Table 93. Kuwait topical hemostat market, by application, 2018 - 2030 (USD Million)
  • Table 94. Kuwait topical hemostat market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Topical hemostat market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Topical hemostat market, type outlook key takeaways (USD Million)
  • Fig. 12 Topical hemostat market type movement analysis 2023 & 2030 (USD Million)
  • Fig. 13 Fibrin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Thrombin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Cellulose market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Collagen market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Gelatin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Adhesives market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Topical hemostat market, application outlook key takeaways (USD Million)
  • Fig. 21 Topical hemostat market application movement analysis 2023 & 2030 (USD Million)
  • Fig. 22 General surgery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Neurosurgery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Vascular surgery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cardiovascular surgery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Topical hemostat market, end-use outlook key takeaways (USD Million)
  • Fig. 28 Topical hemostat market end-use movement analysis 2023 & 2030 (USD Million)
  • Fig. 29 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Topical hemostat market: Regional key takeaways (USD Million)
  • Fig. 33 Topical hemostat market regional outlook, 2023 & 2030 (USD Million)
  • Fig. 34 North America topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 US topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Australia topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 List of key emerging company's/technology disruptors/innovators